Enovix (NASDAQ:ENVX) Sets New 52-Week Low – Should You Sell?

Shares of Enovix Corporation (NASDAQ:ENVX) reached a new 52-week low during mid-day trading on Friday . The stock traded as low as $4.57 and last traded at $4.70, with a volume of 8709298 shares. The stock had previously closed at $5.11.

Analyst Ratings Changes

Several research firms have recently commented on ENVX. Benchmark reduced their target price on Enovix from $25.00 to $15.00 and set a “buy” rating for the company in a research note on Thursday, May 14th. Weiss Ratings restated a “sell (e+)” rating on shares of Enovix in a research note on Wednesday, July 8th. Oppenheimer cut their price target on shares of Enovix from $24.00 to $21.00 and set an “outperform” rating on the stock in a report on Thursday, May 14th. Wall Street Zen upgraded shares of Enovix from a “strong sell” rating to a “sell” rating in a research note on Saturday, May 16th. Finally, JPMorgan Chase & Co. downgraded shares of Enovix from a “neutral” rating to an “underweight” rating in a research note on Wednesday, May 6th. Seven analysts have rated the stock with a Buy rating, one has given a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat.com, Enovix has a consensus rating of “Moderate Buy” and a consensus target price of $12.64.

Enovix Stock Performance

The firm has a market capitalization of $1.03 billion, a price-to-earnings ratio of -5.69 and a beta of 2.26. The company has a 50-day moving average of $6.44 and a 200-day moving average of $6.36. The company has a current ratio of 10.97, a quick ratio of 10.65 and a debt-to-equity ratio of 2.14.

Enovix (NASDAQ:ENVX) last posted its quarterly earnings results on Wednesday, May 13th. The company reported ($0.14) EPS for the quarter, beating the consensus estimate of ($0.15) by $0.01. Enovix had a negative net margin of 499.64% and a negative return on equity of 64.28%. The business had revenue of $7.60 million during the quarter, compared to analyst estimates of $6.95 million. During the same period in the previous year, the business posted ($0.15) EPS. The company’s quarterly revenue was up 49.1% on a year-over-year basis. Enovix has set its Q2 2026 guidance at -0.170–0.130 EPS. On average, equities research analysts forecast that Enovix Corporation will post -0.79 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Enovix

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Private Advisor Group LLC grew its stake in shares of Enovix by 2.7% in the 3rd quarter. Private Advisor Group LLC now owns 46,519 shares of the company’s stock worth $464,000 after purchasing an additional 1,242 shares during the last quarter. Parallel Advisors LLC raised its holdings in shares of Enovix by 51.9% in the 3rd quarter. Parallel Advisors LLC now owns 3,926 shares of the company’s stock worth $39,000 after purchasing an additional 1,342 shares in the last quarter. Equitable Holdings Inc. lifted its stake in Enovix by 10.9% during the third quarter. Equitable Holdings Inc. now owns 13,700 shares of the company’s stock valued at $137,000 after purchasing an additional 1,342 shares during the last quarter. NewEdge Advisors LLC lifted its stake in Enovix by 4.7% during the first quarter. NewEdge Advisors LLC now owns 41,460 shares of the company’s stock valued at $215,000 after purchasing an additional 1,853 shares during the last quarter. Finally, Mariner LLC boosted its holdings in Enovix by 3.4% during the third quarter. Mariner LLC now owns 58,343 shares of the company’s stock worth $582,000 after buying an additional 1,921 shares in the last quarter. 50.92% of the stock is currently owned by institutional investors and hedge funds.

About Enovix

Enovix Corporation (NASDAQ: ENVX) develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.

Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.